CN Patent

CN109790143A — 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体

Assigned to C4 Pharmaceutical Co · Expires 2019-05-21 · 7y expired

What this patent protects

本发明提供了用于如本文进一步描述的治疗应用的胺连接的C 3 ‑戊二酰亚胺降解决定子体和降解决定子，及其使用方法和组合物以及它们的制备方法。

USPTO Abstract

本发明提供了用于如本文进一步描述的治疗应用的胺连接的C 3 ‑戊二酰亚胺降解决定子体和降解决定子，及其使用方法和组合物以及它们的制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN109790143A
Jurisdiction
CN
Classification
—
Expires
2019-05-21
Drug substance claim
No
Drug product claim
No
Assignee
C4 Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.